Shake Shack's stock dropped more than 40% after the company first disappointed investors with weak Q2 guidance on May 7, 2026, and then further lowered its full-year 2026 financial targets on June 2, 2026. The company cut revenue, same-store sales growth, profit margins, and EBITDA projections citing macroeconomic uncertainty and competitive pressures. This sharp downward revision led to a significant loss for shareholders, prompting a securities investigation by Levi & Korsinsky into whether Shake Shack made misleading statements about its financial outlook. Investors who suffered losses are encouraged to contact the law firm for potential legal action.
Ormat Technologies introduced the Ormega100, the industry's largest binary power generation unit delivering 100 MW output, designed to accelerate commercialization and scaling of Enhanced Geothermal Systems (EGS). With 60 years of expertise and exten...
ADARx Pharmaceuticals announced it will present Phase 1/2 clinical data for Onvuzosiran, an RNA therapy for hereditary angioedema (HAE), at the 2026 EAACI Congress in Istanbul. Onvuzosiran targets plasma prekallikrein to prevent swelling attacks by r...
FDH Aero, a leading aerospace and defense supply chain provider, has agreed to a majority investment from Bain Capital Private Equity, with Audax Private Equity remaining a significant investor. This partnership aims to accelerate FDH's growth strate...
Cyabra, an AI-driven disinformation intelligence company, has secured a contract worth over $500,000 to provide its technology to a leading international research institute focused on tracking global hate speech. The platform will help identify coord...
Novo Nordisk announced positive Phase 3 trial results for CagriSema, a once-weekly therapy combining an amylin analog with a GLP-1 receptor agonist, which significantly reduced HbA1c and body weight in adults with Type 2 diabetes. The company also sh...
